Categoria

Immediapress- Pagina 259

3 minuti di lettura

Appian and PSI CRO Form Strategic Partnership to Advance AI-driven Clinical Trial Operations

First joint project launches a broader platform strategy for process orchestration across the clinical trial lifecycle BERLIN, Oct. 28, 2026 /PRNewswire/ — Appian (Nasdaq: APPN) and PSI CRO announced today the launch

Immediapress

Farizon SV Model Year 2027 makes its French debut at Rungis, tested for real-world delivery

PARIS, Oct. 28, 2026 /PRNewswire/ — Geely Farizon unveiled the Farizon SV Model Year 2027 at Marché International de Rungis, the world’s premier fresh produce wholesale hub. A benchmark for European last‑mile delivery, Rungis demands dense multi‑drop routes, tight timetables

CELSET Launches SOLTOX, a Korean Botulinum Toxin Type A Brand, for International Markets

Immediapress

SEOUL, South Korea, Oct. 28, 2026 /PRNewswire/ — CELSET INC., a Korean biotechnology company specializing in medical aesthetics, has launched SOLTOX, its botulinum toxin

Rivermate recognized as a key provider of EoR solutions in Everest Group’s Employer of Record (EoR) Solutions PEAK Matrix® Assessment 2026

Immediapress

DUBAI, UAE and LONDON, Oct. 28, 2026 /PRNewswire/ — Rivermate, the Employer of Record platform helping companies hire and pay talent in more than

Industrial Storytelling and Cross-City Synergy: Hangzhou and Paris in Dialogue

venerdì, 31 Luglio 2026

Immediapress

PARIS and HANGZHOU, China, July 31, 2026 /PRNewswire/ — Paris and Hangzhou, though separated by thousands of miles, have long shared an unspoken affinity. That affinity gained fresh meaning at the Hangzhou Promotion

Industrial Storytelling and Cross-City Synergy: Hangzhou and Paris in Dialogue

venerdì, 31 Luglio 2026

Immediapress

MOYOM Advances European Regenerative Aesthetics Through APHRANEL® EU MDR Certification and Strategic Scientific Collaboration with Expert2Expert

venerdì, 31 Luglio 2026

Immediapress

LONDON, July 31, 2026 /PRNewswire/ — MOYOM, the biotechnology company behind APHRANEL®, today announced two major milestones in its European strategy: the achievement of European Medical Device Regulation (EU MDR) certification for

MOYOM Advances European Regenerative Aesthetics Through APHRANEL® EU MDR Certification and Strategic Scientific Collaboration with Expert2Expert

venerdì, 31 Luglio 2026

Immediapress

IMPACT Therapeutics Signs Exclusive License Agreement with Pharmanovia for Senaparib in Europe, Middle East and North Africa, Australia and New Zealand

venerdì, 31 Luglio 2026

Immediapress

SHANGHAI, July 31, 2026 /PRNewswire/ — IMPACT Therapeutics (“IMPACT”) (07630.HK) is pleased to announce that it has entered into an exclusive partnership (the “Exclusive Partnership”) with Pharmanovia, a global specialty pharmaceutical company

IMPACT Therapeutics Signs Exclusive License Agreement with Pharmanovia for Senaparib in Europe, Middle East and North Africa, Australia and New Zealand

venerdì, 31 Luglio 2026

Immediapress

Envision Delivers Low-Carbon Ammonia Environmental Attribute Certificates to PepsiCo APAC, Pioneering Decarbonization in the Fertilizer Industry

venerdì, 31 Luglio 2026

Immediapress

SHANGHAI, July 31, 2026 /PRNewswire/ — On July 30th 2026, Envision Energy, a global leader in green technology, announced a low carbon ammonia environmental attribute purchase agreement with PepsiCo APAC and completed

Envision Delivers Low-Carbon Ammonia Environmental Attribute Certificates to PepsiCo APAC, Pioneering Decarbonization in the Fertilizer Industry

venerdì, 31 Luglio 2026

Immediapress

Sicurezza, Very Alarm accelera la crescita e punta su rete nazionale e servizi ricorrenti

venerdì, 31 Luglio 2026

Immediapress

Nata nel 2023, Very Alarm ha superato nel 2025 il milione di euro di fatturato e si prepara ora a una nuova fase di sviluppo. La società fondata da Andrea Inverardi opera

Delay is Unacceptable | Petrus Recommends Shareholders Not to Tender at €14.10 per Share

giovedì, 30 Luglio 2026

Immediapress

ST. HELIER, Jersey and LONDON, July 30, 2026 /PRNewswire/ — Petrus Legal Strategies (Jersey) Limited, Petrus Advisers Limited and funds advised by Petrus Advisers Limited (together, “Petrus”), which together hold between 3%

Indietro 1 … 257 258 259 260 261 … 2.401 Avanti

Suggerimenti

Immediapress- Pagina 259